AU6689700A - Method of treating psoriasis with il-15 antagonist - Google Patents

Method of treating psoriasis with il-15 antagonist

Info

Publication number
AU6689700A
AU6689700A AU66897/00A AU6689700A AU6689700A AU 6689700 A AU6689700 A AU 6689700A AU 66897/00 A AU66897/00 A AU 66897/00A AU 6689700 A AU6689700 A AU 6689700A AU 6689700 A AU6689700 A AU 6689700A
Authority
AU
Australia
Prior art keywords
antagonist
treating psoriasis
psoriasis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66897/00A
Inventor
Silvia Bulfone-Paus
Rene Ruckert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BULFONE PAUS SILVIA
Original Assignee
BULFONE PAUS SILVIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BULFONE PAUS SILVIA filed Critical BULFONE PAUS SILVIA
Publication of AU6689700A publication Critical patent/AU6689700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU66897/00A 1999-07-06 2000-07-06 Method of treating psoriasis with il-15 antagonist Abandoned AU6689700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14262699P 1999-07-06 1999-07-06
US60142626 1999-07-14
PCT/EP2000/006419 WO2001002003A1 (en) 1999-07-06 2000-07-06 Method of treating psoriasis with il-15 antagonist

Publications (1)

Publication Number Publication Date
AU6689700A true AU6689700A (en) 2001-01-22

Family

ID=22500636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66897/00A Abandoned AU6689700A (en) 1999-07-06 2000-07-06 Method of treating psoriasis with il-15 antagonist

Country Status (2)

Country Link
AU (1) AU6689700A (en)
WO (1) WO2001002003A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519439A (en) * 1998-07-07 2002-07-02 久光製薬株式会社 Antisense oligonucleotides targeted to IL-15
US7247304B2 (en) 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
NZ531211A (en) * 2001-08-23 2007-04-27 Genmad As Human antibodies specific for interleukin 15 (IL-15)
US7329405B2 (en) 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
JP4892335B2 (en) * 2003-02-26 2012-03-07 ゲンマブ エー／エス Human antibody specific for interleukin-15 (IL-15)
CU23472A1 (en) * 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech ANTAGONIST PEPTIDE OF INTERLEUCINE-15
CU23716A1 (en) * 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech ANTAGONIST PEPTIDE OF THE ACTIVITY OF INTERLEUCINA-15
DE102013207156A1 (en) 2013-04-19 2014-10-23 Adidas Ag Shoe, in particular a sports shoe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
CA2252557A1 (en) * 1996-04-26 1997-11-06 Beth Israel Deaconess Medical Center, Inc. Antagonists of interleukin-15
DE19823351A1 (en) * 1997-05-16 1998-12-10 Krause Hans Agent for inhibiting apoptosis

Also Published As

Publication number Publication date
WO2001002003A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU7051000A (en) Method of activity based costing
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
PL342076A1 (en) Method of treating surfaces
HUP0200738A3 (en) Method of the treatment of incontinence
EP1164156A4 (en) Method of polymerizing silalkylenesiloxane
AU6689700A (en) Method of treating psoriasis with il-15 antagonist
AU3082401A (en) Therapy of psoriasis
AU4552200A (en) Method of treating psychotic disorders
AU3757300A (en) Method of treating anxiety disorders
AU1133901A (en) Method of treating metabolic disorders
AU3009401A (en) Method of treating fabrics
AUPP508798A0 (en) Method of treating psoriasis
AU5861700A (en) Method of threading
GB9930688D0 (en) Novel method of treatment
AU4598400A (en) Method of treatment
GB9924752D0 (en) Method of construction
AU4985200A (en) Methods of treating hypertension
AU3476300A (en) Improved mouse and method of using
AU2382601A (en) Novel method of treatment
AU3898600A (en) Method of treating obsessive-compulsive disorder
AU1784701A (en) Method of treating neuroblastoma
AU8031700A (en) Method of treating fibrosis
TJ99000555A (en) Method of treatment of psoriasis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase